Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
16,440,909
-
Share change
-
+960,306
-
Total reported value
-
$135,304,372
-
Put/Call ratio
-
6.8%
-
Price per share
-
$8.23
-
Number of holders
-
75
-
Value change
-
+$7,921,242
-
Number of buys
-
39
-
Number of sells
-
21
Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) as of Q3 2022
As of 30 Sep 2022,
AVEO PHARMACEUTICALS INC - COM NEW (AVEO) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,440,909 shares.
The largest 10 holders included
NEA Management Company, LLC, AIGH Capital Management LLC, Rubric Capital Management LP, VANGUARD GROUP INC, Worth Venture Partners, LLC, J. Goldman & Co LP, EcoR1 Capital, LLC, BlackRock Inc., EAM Investors, LLC, and GLOBEFLEX CAPITAL L P.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.